• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction.

作者信息

Truss M C, Becker A J, Djamilian M H, Stief C G, Jonas U

机构信息

Department of Urology, Medizinische Hochschule Hannover, Germany.

出版信息

Urology. 1994 Oct;44(4):553-6. doi: 10.1016/s0090-4295(94)80058-8.

DOI:10.1016/s0090-4295(94)80058-8
PMID:7941195
Abstract

OBJECTIVES

Recently, nitric oxide was shown to be a mediator of penile erection in men and the nitric oxide donor linsidomine chlorhydrate (SIN-1) was introduced as a novel treatment option in patients with erectile dysfunction. We now present our follow-up results with the intracavernous application of SIN-1.

METHODS

One hundred thirteen patients with erectile dysfunction of various etiologies and 10 normal control subjects underwent intracavernous pharmacotesting with 1 mg SIN-1. Of the 113 patients, 71 (62.8%) underwent additional pharmacotesting with a mixture of papaverine (15 mg/mL) and phentolamine (0.5 mg/mL) (P/P). Forty-eight responders to SIN-1 were enrolled in an autoinjection program with this substance.

RESULTS

All normal control subjects had full rigid erections lasting 40 to 70 minutes. Of 113 patients, 78 (69%) had responses sufficient for intercourse with SIN-1, and the other 35 patients (31%) demonstrated inadequate responses. All 44 responders to SIN-1 who also received P/P had erections sufficient for intercourse with P/P in doses of 0.25 to 2 mL (mean, 0.6 +/- 0.3 mL). Six patients (13.6%) had prolonged erections with minimal to moderate doses of P/P. From the total of 27 patients who had erections insufficient for intercourse with SIN-1, 20 (74.1%) had good responses with 0.25 to 2.0 mL P/P (mean, 1.5 +/- 0.5 mL). One patient (4%) had a prolonged erection with 1.0 mL P/P: After 10 to 150 injections/patient (total of 1160 injections; mean, 24.1 injections), no significant side effects were noted with SIN-1.

CONCLUSIONS

Our data suggest that intracavernous SIN-1 is safe and efficacious in the majority of patients with erectile dysfunction; however, it has a lower smooth muscle relaxing effect than a combination of P/P. The absence of severe side effects, including priapisms, may be explained by the use of a physiologic pathway for induction of the erectile response and the rapid intracavernous decomposition of SIN-1.

摘要

相似文献

1
Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction.
Urology. 1994 Oct;44(4):553-6. doi: 10.1016/s0090-4295(94)80058-8.
2
Preliminary results with the nitric oxide donor linsidomine chlorhydrate in the treatment of human erectile dysfunction.一氧化氮供体盐酸林西多明治疗人类勃起功能障碍的初步结果。
J Urol. 1992 Nov;148(5):1437-40. doi: 10.1016/s0022-5347(17)36931-8.
3
Nitric oxide donor, linsidomine chlorhydrate (SIN-1), in the diagnosis and treatment of erectile dysfunction: critical appraisal and review of the literature.
Int Urol Nephrol. 1995;27(5):621-8. doi: 10.1007/BF02564750.
4
Effect of nitric oxide-donor, linsidomine chlorhydrate, in treatment of human erectile dysfunction caused by venous leakage.一氧化氮供体盐酸罂粟碱治疗静脉性漏血所致男性勃起功能障碍的疗效
Urology. 1993 Oct;42(4):409-11. doi: 10.1016/0090-4295(93)90371-g.
5
Prostaglandin E1 versus linsidomine chlorhydrate in erectile dysfunction.前列腺素E1与盐酸林西多明治疗勃起功能障碍的比较
Urol Int. 1994;53(4):214-6. doi: 10.1159/000282674.
6
Efficacy of linsidomine chlorhydrate, a direct nitric oxide donor, in the treatment of human erectile dysfunction: results of a double-blind cross over trial.
Int J Impot Res. 1995 Dec;7(4):233-7.
7
Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.阴茎海绵体内注射药物治疗男性勃起功能障碍:100例患者的经验
J Urol. 1986 Apr;135(4):704-6. doi: 10.1016/s0022-5347(17)45825-3.
8
[Pharmacological therapy in erectile dysfunction--current standards and new viewpoint].
Wien Med Wochenschr. 1997;147(4-5):102-4.
9
How safe is the treatment of impotence with intracavernous autoinjection?
Eur Urol. 1989;16(3):165-71. doi: 10.1159/000471562.
10
Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.海绵体内注射:仍是老年男性勃起功能障碍治疗的金标准。
Int J Impot Res. 2001 Jun;13(3):172-5. doi: 10.1038/sj.ijir.3900672.

引用本文的文献

1
Cysteine-Rich Whey Protein Isolate (CR-WPI) Ameliorates Erectile Dysfunction by Diminishing Oxidative Stress via DDAH/ADMA/NOS Pathway.乳清蛋白分离物中的半胱氨酸(CR-WPI)通过 DDAH/ADMA/NOS 通路减轻氧化应激,从而改善勃起功能障碍。
Oxid Med Cell Longev. 2022 Mar 21;2022:8151917. doi: 10.1155/2022/8151917. eCollection 2022.
2
NO donors and NO delivery methods for controlling biofilms in chronic lung infections.慢性肺部感染中无供体且无输送方法来控制生物膜。
Appl Microbiol Biotechnol. 2021 May;105(10):3931-3954. doi: 10.1007/s00253-021-11274-2. Epub 2021 May 3.
3
Nitrergic Mechanisms for Management of Recurrent Priapism.
复发性阴茎异常勃起治疗的一氧化氮机制
Sex Med Rev. 2015 Jul 1;3(3):160-168. doi: 10.1002/smrj.56. Epub 2015 Jun 4.
4
The role of nitric oxide in erectile dysfunction: implications for medical therapy.一氧化氮在勃起功能障碍中的作用:对药物治疗的启示。
J Clin Hypertens (Greenwich). 2006 Dec;8(12 Suppl 4):53-62. doi: 10.1111/j.1524-6175.2006.06026.x.
5
Pharmacologic treatment of erectile dysfunction.勃起功能障碍的药物治疗
Rev Urol. 2002;4 Suppl 3(Suppl 3):S17-25.
6
Intracavernous pharmacotherapy for erectile dysfunction.阴茎海绵体内药物治疗勃起功能障碍。
Endocrine. 2004 Mar-Apr;23(2-3):149-55. doi: 10.1385/ENDO:23:2-3:149.
7
Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone.环鸟苷酸(cGMP)途径与环磷酸腺苷(cAMP)途径之间的相互作用参与阴茎平滑肌张力的调节。
World J Urol. 2004 Oct;22(4):261-6. doi: 10.1007/s00345-003-0394-4. Epub 2004 Mar 26.
8
Immunocytochemical distribution of nitric oxide synthase in the human seminal vesicle: a light and electron microscopical study.人精囊一氧化氮合酶的免疫细胞化学分布:光镜和电镜研究
Urol Res. 2003 Aug;31(4):262-6. doi: 10.1007/s00240-003-0322-5. Epub 2003 Jun 12.
9
Activation and potentiation of the NO/cGMP pathway by NG-hydroxyl-L-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing.在常氧、缺氧条件及衰老状态下,NG-羟基-L-精氨酸对兔海绵体中NO/cGMP途径的激活与增强作用
Br J Pharmacol. 2003 Jan;138(1):63-70. doi: 10.1038/sj.bjp.0705027.
10
Comparative tolerability and efficacy of treatments for impotence.阳痿治疗方法的耐受性和疗效比较
Drug Saf. 1999 Feb;20(2):133-46. doi: 10.2165/00002018-199920020-00004.